missing translation for 'onlineSavingsMsg'
Learn More

enQuireBio™ Recombinant Human LGALS8 Protein

Product Code. 15925108
Click to view available options
Quantity:
1 mg
10 μg
2 μg
Unit Size:
10µg
1mg
2µg
This item is not returnable. View return policy

Product Code. 15925108

Brand: enQuireBio™ QP1076810ug

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

A cDNA sequence encoding the LGALS8 was constructed and used to recombinantly synthesize the protein.

Specifications

Name LGALS8 Protein
Quantity 10 μg
Regulatory Status Research Use Only
Endotoxin Concentration < 1.0 EU per ug protein as determined by the LAL method.
Biological Activity The ED50 of Galectin-8 as determined by its ability to agglutinate human red blood cells is 0.8∼4 microg/ml.
Product Type Recombinant Protein
Cross Reactivity Human
Species E. coli
Protein Tag Untagged
Sequence MMLSLNNLQN IIYNPVIPFV GTIPDQLDPG TLIVIRGHVP SDADRFQVDL QNGSSMKPRA DVAFHFNPRF KRAGCIVCNT LINEKWGREE ITYDTPFKRE KSFEIVIMVL KDKFQVAVNG KHTLLYGHRI GPEKIDTLGI YGKVNIHSIG FSFSSDLQST QASSLELTEI SRENVPKSGT PQLRLPFAAR LNTPMGPGRT VVVKGEVNAN AKSFNVDLLA GKSKDIALHL NPRLNIKAFV RNSFLQESWG EEERNITSFP FSPGMYFEMI IYCDVREFKV AVNGVHSLEY KHRFKELSSI DTLEINGDIH LLEVRSW
Buffer LGALS8 was lyophilized from a concentrated (1 mg/ml) solution in 20mM PBS, pH 7.4.
Purity or Quality Grade Greater than 95.0% as determined by:(a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.